Table 5 Exclusion criteria
Exclusion criteria | Notes |
|---|---|
Null entries | No information is reported in title and abstract fields |
Duplicates | Duplicate of an existing entry |
Not in the language of interest | English only |
Abstract that is reported elsewhere | A conference abstract with the content reported in another publication |
Not study type of interest | Not a cost-effectiveness analysis |
Not HPV vaccination | Not including an arm of HPV vaccination ± screening |
Not the country of interest | Countries of interest include: Austria, Belgium, Switzerland, Czech Republic, Germany, Denmark, Spain, Finland, France, Greece, Ireland, Italy, the Netherlands, Norway, Poland, Portugal, Sweden, Slovenia, and the UK, the US, Canada and Australia |
No outcome of interest | Health economic endpoints |